Parkman Healthcare Partners as of March 31, 2021
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 83 positions in its portfolio as reported in the March 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aclaris Therapeutics (ACRS) | 10.0 | $43M | 1.7M | 25.20 | |
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 3.7 | $16M | 50k | 319.14 | |
Danaher Corporation (DHR) | 3.4 | $15M | 65k | 225.08 | |
Charles River Laboratories (CRL) | 3.4 | $15M | 50k | 289.84 | |
Natera (NTRA) | 3.3 | $14M | 140k | 101.54 | |
Humana (HUM) | 3.2 | $14M | 33k | 419.24 | |
Icad Com New (ICAD) | 3.2 | $14M | 648k | 21.22 | |
Dex (DXCM) | 3.1 | $14M | 38k | 359.38 | |
Iqvia Holdings (IQV) | 3.0 | $13M | 66k | 193.15 | |
United Therapeutics Corporation (UTHR) | 2.9 | $13M | 75k | 167.27 | |
Peregrine Pharmaceuticals (CDMO) | 2.9 | $12M | 675k | 18.23 | |
Amgen (AMGN) | 2.6 | $11M | 45k | 248.81 | |
Alnylam Pharmaceuticals (ALNY) | 2.1 | $9.2M | 65k | 141.18 | |
Arcus Biosciences Incorporated (RCUS) | 2.1 | $8.9M | 316k | 28.08 | |
Acceleron Pharma | 2.0 | $8.5M | 63k | 135.62 | |
Catalent | 1.9 | $8.4M | 80k | 105.31 | |
Insulet Corporation (PODD) | 1.9 | $8.1M | 31k | 260.93 | |
Itamar Med Sponsored Ads | 1.9 | $8.1M | 336k | 23.95 | |
Dicerna Pharmaceuticals | 1.8 | $7.8M | 303k | 25.57 | |
Avantor (AVTR) | 1.7 | $7.3M | 252k | 28.93 | |
Xenon Pharmaceuticals (XENE) | 1.6 | $6.7M | 374k | 17.90 | |
Oncternal Therapeutics | 1.5 | $6.5M | 779k | 8.32 | |
Immunic (IMUX) | 1.5 | $6.4M | 401k | 15.94 | |
Horizon Therapeutics Pub L SHS | 1.5 | $6.3M | 68k | 92.04 | |
Vericel (VCEL) | 1.4 | $6.1M | 110k | 55.55 | |
InfuSystem Holdings (INFU) | 1.3 | $5.7M | 279k | 20.36 | |
Gossamer Bio (GOSS) | 1.3 | $5.4M | 583k | 9.25 | |
Edap Tms S A Sponsored Adr (EDAP) | 1.1 | $4.8M | 573k | 8.40 | |
Ionis Pharmaceuticals (IONS) | 1.1 | $4.8M | 106k | 44.96 | |
Arrowhead Pharmaceuticals (ARWR) | 1.1 | $4.6M | 70k | 66.32 | |
Madrigal Pharmaceuticals (MDGL) | 1.1 | $4.6M | 40k | 116.97 | |
Sutro Biopharma (STRO) | 1.1 | $4.6M | 203k | 22.76 | |
Stereotaxis Com New (STXS) | 1.1 | $4.5M | 676k | 6.72 | |
Axogen (AXGN) | 1.0 | $4.3M | 212k | 20.26 | |
Bridgebio Pharma (BBIO) | 0.9 | $4.0M | 65k | 61.60 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.9 | $4.0M | 113k | 35.64 | |
Nuance Communications | 0.9 | $4.0M | 91k | 43.64 | |
Kodiak Sciences (KOD) | 0.9 | $3.7M | 33k | 113.38 | |
IDEXX Laboratories (IDXX) | 0.9 | $3.7M | 7.6k | 489.26 | |
Outset Med (OM) | 0.8 | $3.5M | 65k | 54.38 | |
Seaspine Holdings | 0.8 | $3.3M | 191k | 17.40 | |
Kadmon Hldgs | 0.7 | $3.2M | 825k | 3.89 | |
Dentsply Sirona (XRAY) | 0.7 | $3.2M | 50k | 63.82 | |
Schrodinger (SDGR) | 0.7 | $3.1M | 41k | 76.29 | |
Health Catalyst (HCAT) | 0.7 | $3.1M | 65k | 46.77 | |
Cooper Cos Com New | 0.7 | $2.9M | 7.5k | 384.13 | |
BioCryst Pharmaceuticals (BCRX) | 0.6 | $2.5M | 245k | 10.17 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.6 | $2.5M | 15k | 164.40 | |
89bio (ETNB) | 0.6 | $2.4M | 102k | 23.68 | |
Atreca Cl A Com (BCEL) | 0.5 | $2.3M | 152k | 15.33 | |
Codexis (CDXS) | 0.5 | $2.3M | 100k | 22.89 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $2.3M | 76k | 29.87 | |
Curis Com New | 0.5 | $2.2M | 196k | 11.32 | |
Molecular Templates | 0.5 | $2.1M | 166k | 12.62 | |
Catalyst Biosciences Com New | 0.5 | $2.0M | 392k | 5.04 | |
Surface Oncology | 0.5 | $2.0M | 252k | 7.80 | |
Haemonetics Corporation (HAE) | 0.5 | $1.9M | 18k | 111.03 | |
1life Healthcare | 0.4 | $1.8M | 45k | 39.08 | |
Profound Med Corp Com New (PROF) | 0.4 | $1.7M | 84k | 20.14 | |
Recro Pharma | 0.4 | $1.7M | 602k | 2.79 | |
Trillium Therapeutics Com New | 0.4 | $1.6M | 150k | 10.74 | |
Performant Finl | 0.4 | $1.6M | 750k | 2.15 | |
Alphatec Hldgs Com New (ATEC) | 0.4 | $1.6M | 100k | 15.79 | |
Mannkind Corp Com New (MNKD) | 0.4 | $1.6M | 400k | 3.92 | |
Inotiv (NOTV) | 0.3 | $1.5M | 75k | 20.00 | |
Kiniksa Pharmaceuticals Com Cl A | 0.3 | $1.5M | 81k | 18.51 | |
Fulcrum Therapeutics (FULC) | 0.3 | $1.5M | 126k | 11.78 | |
Turning Point Therapeutics I | 0.3 | $1.3M | 14k | 94.61 | |
Aerpio Pharmaceuticals | 0.3 | $1.3M | 1.0M | 1.29 | |
Soc Telemed Com Cl A | 0.3 | $1.2M | 192k | 6.29 | |
Biolinerx Sponsored Ads (BLRX) | 0.3 | $1.2M | 430k | 2.79 | |
Phathom Pharmaceuticals (PHAT) | 0.3 | $1.1M | 30k | 37.57 | |
Aslan Pharmaceuticals Ads | 0.3 | $1.1M | 325k | 3.35 | |
Forte Biosciences | 0.2 | $1.1M | 31k | 34.27 | |
Silk Road Medical Inc Common | 0.2 | $1.0M | 20k | 50.65 | |
Kala Pharmaceuticals | 0.2 | $1000k | 148k | 6.74 | |
Repro-Med Systems (KRMD) | 0.2 | $921k | 262k | 3.52 | |
Rapt Therapeutics (RAPT) | 0.2 | $896k | 40k | 22.20 | |
Castlight Health CL B | 0.2 | $756k | 500k | 1.51 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $644k | 50k | 12.99 | |
Butterfly Network Com Cl A (BFLY) | 0.1 | $510k | 30k | 16.82 | |
Apollo Endosurgery | 0.1 | $413k | 75k | 5.51 | |
Eyegate Pharmaceuticals Com New | 0.1 | $375k | 75k | 4.98 |